SlideShare a Scribd company logo
1 of 57
STIs in men who have sex with
men (MSM)
Dr Katie Conway
October 2015
Introduction
• Epidemiology of STIs in MSM
• Reasons for high rates in MSM
• Changing epidemics
• Cases
• Learning points
Epidemiology
PHE report on MSM in London - 2014
• 2% of London adult population
• 24% of all new STI diagnoses
• Rising rates of STIs
– 46% syphilis
– 32% gonorrhoea
– 26% chlamydia
• High re-infection rates
• High burden of gonorrhoea and syphilis
Public Health England: HIV and STIs in men who have sex with men in London, September 2014
Public Health England: HIV and STIs in men who have sex with men in London, September 2014
Percentage of all STI diagnoses in men which were
among MSM: England, 2009-2013
39 Public Health England: 2013 STI Slide Set
• Data from routine GUM service returns
• * First episode; **Includes diagnoses of primary, secondary & early latent syphilis
• Chlamydia data from 2012 onwards are not comparable to data from previous years (please see ‘Notes’ slide for more details)
• Data type: service data
HIV
• 50% new diagnoses are in MSM
• Globally MSM have disproportionate burden
of HIV infection
Epidemiology
HIV in SriLanka
National STD/AIDS Control Programme Annual Report 2014
Sunday Observer -27/11/2011
http://www.sundayobserver.lk/2011/11/27/fea06.asp
STI / HIV transmission in MSM
Biological
Behavioural
Social
HIV transmission in MSM
• Biological factors
– Receptive anal sex
– Concurrent STIs – often asymptomatic
Behavioural
• High partner numbers:
– EMIS1 2010: 60% sexual contact within 7 days
70% >1 partner within 12 months
HIV –ve MSM 34% 10 partners in 1 year
– NATSAL 20002: Skewed distribution
Median 1 partner per year
15% > 10 partners per year
– Overlapping / concurrent partners
– Sexual mixing of MSM with high and low partner no.s
1EMIS. Vital Statistics 2010:The UK Gay Men's Sex Survey Data Report All London SHA by PCT area
of residence. 2010.
2Mercer C Fk et al. Increasing prevalence of male homosexual partnershipsand practices in Britain
1990-2000: evidence from national probability surveys. AIDS 2004. 2004;18:1453-8.
Behavioural
• Survey MSM London gyms3: 36% UPAI in last 3/12
• EMIS1: 40% UPAI last sexual intercourse
• GMSHS, 20084; in the last year:
– UPAI in HIV +ve MSM – 57.7% (49.6% in 2000)
– UPAI in HIV –ve MSM – 46.6% (42.2% in 2000)
• Seroadaptive behaviour
• ‘Chemsex’
3Lattimore S TA et al; Changing patterns of sexual risk behavior among London gay men: 1998-2008. Sex Transm
Dis. 2011;38(3):221-9.
4Wayal S FS et al; Gay Men's Sexual Health Survey, London 2008. Centre for Sexual Health & HIV Research,
Research Department of Infection & Population health, University College London, 2008.
Other factors
• Stigma
• Rates of engagement with services (UK)
• Often ‘hidden’ epidemics in many countries
• Often difficult partner notification
• High rates of depression / mental health
problems
Depression and sexual behaviour in
MSM – Aurah study. BASHH 2015
STIs in MSM
Specific epidemics:
• Lymphogranuloma Venereum (LGV)
• Shigella flexneri
• Hepatitis C (HCV)
• Syphilis
LGV
• Chlamydia trachomatis
• D to K = genital infection
• L1 , L2 & L3 = lymphogranuloma venereum (LGV)
– Infect lymphocytes & macrophages
– Invasive pathogens
• Primary – ulcer / proctitis (98%)
– Incubation period 4-21 days
• Secondary – inguinal syndrome
– Incubation period 10 days to 6 months
• Tertiary stages
1980s
Original
descriptions of
MSM with LGV
proctitis in
Seattle & San
Francisco
1990s
LGV not
reported
in Western
MSM
Jan
2003
First of four cases of
LGV in Hamburg
MSM, 2003
Australian
LGV L2 bubo
case - no
travel history
Aug
2004
Dutch LGV
cases reach
>100
Sep
2004
Oct
2004
First US cases in
San Francisco
Nov
2004
Dec
2004
Barcelona
case
First
Swedish &
Canadian
cases
Jan
2004
Appearance of LGV in
Rotterdam, then
Amsterdam, Antwerp
and Paris
Feb
2003
Sustained
LGV
outbreaks
within
Europe, UK
and USA
2005-2014
2000
to
2003
Retrospective analysis of MSM
rectal specimens Amsterdam,
Paris and London = 126 cases
LGV L2
A recent timeline of LGV infection in MSM
LGV
Public Health England: HIV and STIs in men who have sex with men in London, September 2014
LGV
• Associations:
– 82% HIV +ve; 20% Hep C Ab +ve
– UPAI
– Fisting
– Partners through the internet / saunas / sex
parties
– Dense sexual networks
– Simultaneous contacts
– Poly-drug use
Health Protection Agency. Syphilis and Lymphogranuloma Venereum: Resurgent
Sexually Transmitted Infections in the UK. In: Agency HP, editor. 2009.
Shigella flexneri 3a isolates, adult males
with no/unknown travel history: 2005-2013
• 750% rise 2008-13
• 60% cases in London
Hepatitis C
• 2002-2006: 20% increase in incidence per year
• HIV positive MSM
• Associated with:
– Previous syphilis infection
– Another recent STI diagnosis
– UPAI
– IDU
– Recreational drug use
– High rates of partner change
Public Health England: HIV and STIs in men who have sex with men in London, September 2014
Syphilis
• Treponema Pallidum – spirochete bacterium
• Transmission – sexual / vertical /(blood borne)
• 1/3 sexual contacts of infectious syphilis will develop
disease
• 4 stages:
– Primary / secondary / early latent - infectious
– Late latent
– Tertiary
• Histopathological hallmarks:
– Endarteritis
– Plasma cell–rich infiltrate
Cases
Case 1
• 25 year old MSM, Italian
• No PMH / DH
• PC:
– Worsening perianal pain and discharge 2/12
– Accident and Emergency department 04/2015
– Admitted under surgical team
– Diagnosed with a fissure
– Discharged with diltiazem topical cream
Case 1
• Seen in surgical OP 6 weeks later
• Ongoing symptoms
• Took a sexual history and referred to GU clinic
• Examination:
– Perianal ulcer
– Rectal discharge and contact bleeding
• Full STI screen done
• Treated empirically with doxycycline and aciclovir
Case 1
• Provisional results:
– Treponema pallidum antibody positive
– RPR 1:64
– Ulcer swab – TP PCR positive (HSV negative)
– HIV 1 Ag/Ab positive
– Rectal CT NAAT positive
– Rectal GC NAAT positive
– Hepatitis C antibodies positive
Case 1
• Treated with:
– Ceftriaxone 500mg im
– Doxycycline completed 3 weeks
• LGV specific DNA positive
• HIV
– CD4 1446 cells/mm3
– VL 76000 copies/mL
• Hepatitis C RNA 4 million
• Genotype 1a
Issues
• Partner notification:
– Reported 1 RMP since last sexual health screen 3
months before
• Further management
– Offer HIV treatment
• Hepatitis C treatment - discuss
• Feedback to surgical team and A&E
Case 2
• 60 year old MSM
• HIV positive, stable on ART
• CD4 600, VL < 20 copies/mL
• RMP – monogamous relationship, 2 years
• Presented to GP with right inguinal lump
• Referred to surgeons ? Hernia
• US – lymph node mass
Case 2
• Discussed the differential diagnoses:
– Syphilis
– LGV
– Lymphoma
– Mycobacterial infection
– KS
Case 2
• Partner admits he was diagnosed with syphilis
few days ago…
• Treated with benzathine penicillin and
doxycycline 3/52 to cover both syphilis and
LGV
Case 2
• Results:
• TP Antibody positive
• RPR 1:128
• Rectal, throat and urine NAATs negative for
GC/CT
• After 1 week – LN still enlarged and painful
Case 2
• Repeat US – no collection
• FNA:
– no malignant cells
– AFB smear negative
– NAAT positive for chlamydia
– LGV specific DNA detected
• Completed 3 weeks of doxycycline
• Buboe ruptured
• Required a further 1 week Azithromycin until resolved
Case 3
• 46 year old MSM
• Unwell for >6 months
• Chronic diarrhoea
• Peeling skin
• “covered in rashes”
• Patchy alopecia
• Seen in private sector ? Psoriasis ? IBD
Hands
A week later
Feet
• Seen by several specialties
• Several investigations done including colonoscopies
• Treated with prednisolone and mesalazine for
?eosinophilic colitis and for psoriasis
• Everything got worse
• HIV serology: positive
• Last negative test was 18/12 before
• Referred to GU services
• Diagnosed with secondary syphilis
• Confirmatory serology:
– treponemal antibody detected
– RPR 1:512
• Rectal chlamydia & gonorrhoea positive
• Pharyngeal gonorrhoea positive
• Treated with doxycycline (penicillin allergy)
Post
treatment
RPR follow up
• Skin & hair much better
• Started ARVs
• Doing well
• Feedback to other specialties – gastro / derm
Case 4
• 35 year old eastern European man
• Found acting oddly on public transport
• Confused ?had a seizure
• Dropped GCS on admission
• Febrile & tachycardic
• HIV test positive
Imaging
• Initial CT Brain: low attenuation L internal capsule
?acute infarct
• Repeat 3/7 later: large R MCA infarct with midline
shift
• CD4 count 154 cells/mm3, VL 93703 copies/mL
• Wide differential: opportunistic infections vs non HIV
Other investigations
• CSF: WCC 27, protein 1.04, normal glucose
ratio
• CSF virology: negative
• Treponemal DNA DETECTED
• Serology:
– Treponemal antibody DETECTED
– RPR 1:256
MRI Brain
Conclusion:
• Large subacute right MCA territory infarct with
additional smaller infarcts in the left MCA and right ACA
territory.
• MRA shows distal ICA and MCA occlusion on the right side
and moderate to severe terminal ICA and A1/M1 origin
narrowing on the left side
Suggestive of a vasculitic process
Presumed diagnosis: meningovascular syphilis
Treatment
• Started on intravenous benzylpenicillin every 4hrs
• Also given steroids
• Unfortunately deterioration of condition despite full
active treatment
• Deemed in best interests to be DNAR
• Died within 4 weeks of admission
Learning points
• STIs and HIV common in MSM
• Often concurrent infections
• Often present to other services
• Communication and education very important
• STI epidemiology can change
• Surveillance is key
• In HIV, STIs are often atypical
Thank you for your attention!

More Related Content

What's hot

Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and PrioritiesFacing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
DSHS
 
HIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in TexasHIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in Texas
DSHS
 
Can we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovacCan we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovac
PinHealth
 
An std powerpoint
An std powerpointAn std powerpoint
An std powerpoint
carolee430
 
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
Will Zasadny
 

What's hot (18)

Hiv hcv killer twins
Hiv hcv killer twinsHiv hcv killer twins
Hiv hcv killer twins
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
 
HIV/ AIDS Fact Sheet
HIV/ AIDS Fact SheetHIV/ AIDS Fact Sheet
HIV/ AIDS Fact Sheet
 
HIV and AIDS-Diagnosis & Treatment
HIV and AIDS-Diagnosis & TreatmentHIV and AIDS-Diagnosis & Treatment
HIV and AIDS-Diagnosis & Treatment
 
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and PrioritiesFacing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
 
Sex, Drugs & Scotland's Health- Drug use among people living with HIV in Scot...
Sex, Drugs & Scotland's Health- Drug use among people living with HIV in Scot...Sex, Drugs & Scotland's Health- Drug use among people living with HIV in Scot...
Sex, Drugs & Scotland's Health- Drug use among people living with HIV in Scot...
 
HIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in TexasHIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in Texas
 
Laboratory monitoring of Progression of HIV
Laboratory monitoring of  Progression of HIVLaboratory monitoring of  Progression of HIV
Laboratory monitoring of Progression of HIV
 
HIV/STD EPD Overview - Jessica Fridge
HIV/STD EPD Overview -  Jessica FridgeHIV/STD EPD Overview -  Jessica Fridge
HIV/STD EPD Overview - Jessica Fridge
 
HIV/aids and tuberculosis
HIV/aids and tuberculosisHIV/aids and tuberculosis
HIV/aids and tuberculosis
 
Can we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovacCan we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovac
 
Tuberculosis & hiv coexistence
Tuberculosis & hiv coexistenceTuberculosis & hiv coexistence
Tuberculosis & hiv coexistence
 
An std powerpoint
An std powerpointAn std powerpoint
An std powerpoint
 
ChemSex
ChemSexChemSex
ChemSex
 
2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport
 
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
 
Sex, Drugs & Scotland's Health- Positive and negative feelings among people l...
Sex, Drugs & Scotland's Health- Positive and negative feelings among people l...Sex, Drugs & Scotland's Health- Positive and negative feelings among people l...
Sex, Drugs & Scotland's Health- Positive and negative feelings among people l...
 
Tb hiv-coinfection
Tb hiv-coinfectionTb hiv-coinfection
Tb hiv-coinfection
 

Similar to Scientific Sessions 2015: STI in MSM

What is Chemsex? Epidemiology, harms and impacts
What is Chemsex? Epidemiology, harms and impactsWhat is Chemsex? Epidemiology, harms and impacts
What is Chemsex? Epidemiology, harms and impacts
GeorgePanagis3
 
Seminar on hiv diagnosis and management by Dr Sohanlal Sharma
Seminar on hiv diagnosis and management by Dr Sohanlal SharmaSeminar on hiv diagnosis and management by Dr Sohanlal Sharma
Seminar on hiv diagnosis and management by Dr Sohanlal Sharma
Pradeep Singh
 
Impact of DM and its control on the risk of developing TB in Taiwan
Impact of DM and its control on the risk of developing TB in TaiwanImpact of DM and its control on the risk of developing TB in Taiwan
Impact of DM and its control on the risk of developing TB in Taiwan
Ming Chia Lee
 
HIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison RatcliffHIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison Ratcliff
CICM 2019 Annual Scientific Meeting
 

Similar to Scientific Sessions 2015: STI in MSM (20)

Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
 
9. HIV AIDS.pptx
9. HIV AIDS.pptx9. HIV AIDS.pptx
9. HIV AIDS.pptx
 
Wesat2105
Wesat2105Wesat2105
Wesat2105
 
Dr Anna Garner_0.pptx
Dr Anna Garner_0.pptxDr Anna Garner_0.pptx
Dr Anna Garner_0.pptx
 
HIV Transplant Case Report, Transplant Outcomes in Clinical Trials, and Organ...
HIV Transplant Case Report, Transplant Outcomes in Clinical Trials, and Organ...HIV Transplant Case Report, Transplant Outcomes in Clinical Trials, and Organ...
HIV Transplant Case Report, Transplant Outcomes in Clinical Trials, and Organ...
 
Co-infection Linkages
Co-infection LinkagesCo-infection Linkages
Co-infection Linkages
 
What is Chemsex? Epidemiology, harms and impacts
What is Chemsex? Epidemiology, harms and impactsWhat is Chemsex? Epidemiology, harms and impacts
What is Chemsex? Epidemiology, harms and impacts
 
HIV and AIDS
HIV and AIDS HIV and AIDS
HIV and AIDS
 
Screening and Treatment Related Issues in HIV
Screening and Treatment Related Issues in HIVScreening and Treatment Related Issues in HIV
Screening and Treatment Related Issues in HIV
 
Coinfezione HIV HCV
Coinfezione HIV HCVCoinfezione HIV HCV
Coinfezione HIV HCV
 
Testing technologies and STI testing
Testing technologies and STI testingTesting technologies and STI testing
Testing technologies and STI testing
 
Journal Club On LEVELS OF HIV-1 IN SUBGINGIVAL BIOFILM OF HIV-INFECTED PATIE...
Journal Club On LEVELS OF HIV-1 IN SUBGINGIVAL BIOFILM OF HIV-INFECTED PATIE...Journal Club On LEVELS OF HIV-1 IN SUBGINGIVAL BIOFILM OF HIV-INFECTED PATIE...
Journal Club On LEVELS OF HIV-1 IN SUBGINGIVAL BIOFILM OF HIV-INFECTED PATIE...
 
Epidemiology & impact of Sexually Transmitted Infections in Ireland
Epidemiology & impact of Sexually Transmitted Infections in IrelandEpidemiology & impact of Sexually Transmitted Infections in Ireland
Epidemiology & impact of Sexually Transmitted Infections in Ireland
 
Seminar on hiv diagnosis and management by Dr Sohanlal Sharma
Seminar on hiv diagnosis and management by Dr Sohanlal SharmaSeminar on hiv diagnosis and management by Dr Sohanlal Sharma
Seminar on hiv diagnosis and management by Dr Sohanlal Sharma
 
HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)
 
HIV in Kidney Transplantation
HIV in Kidney TransplantationHIV in Kidney Transplantation
HIV in Kidney Transplantation
 
Emergencies Diseases 134287607-Hepatitis-c.ppt
Emergencies Diseases 134287607-Hepatitis-c.pptEmergencies Diseases 134287607-Hepatitis-c.ppt
Emergencies Diseases 134287607-Hepatitis-c.ppt
 
Impact of DM and its control on the risk of developing TB in Taiwan
Impact of DM and its control on the risk of developing TB in TaiwanImpact of DM and its control on the risk of developing TB in Taiwan
Impact of DM and its control on the risk of developing TB in Taiwan
 
HIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison RatcliffHIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison Ratcliff
 
Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
 

More from Sri Lanka College of Sexual Health and HIV Medicine

More from Sri Lanka College of Sexual Health and HIV Medicine (20)

Sexual Health a life cycle perspective
Sexual Health a life cycle perspectiveSexual Health a life cycle perspective
Sexual Health a life cycle perspective
 
SS2017: Understanding gender identity
SS2017: Understanding gender identitySS2017: Understanding gender identity
SS2017: Understanding gender identity
 
SS 2017: Challenges in Hepatitis B Vaccination
SS 2017: Challenges in Hepatitis B VaccinationSS 2017: Challenges in Hepatitis B Vaccination
SS 2017: Challenges in Hepatitis B Vaccination
 
SS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infectionSS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infection
 
SS 2017: Immunotherapy for Genital HPV
SS 2017: Immunotherapy for Genital HPV SS 2017: Immunotherapy for Genital HPV
SS 2017: Immunotherapy for Genital HPV
 
SS 2017: Anal Cancer and its precursors and clinical implications
SS 2017: Anal Cancer and its precursorsand clinical implicationsSS 2017: Anal Cancer and its precursorsand clinical implications
SS 2017: Anal Cancer and its precursors and clinical implications
 
SS 2017: Prevention of cervical cancer
SS 2017: Prevention of cervical cancerSS 2017: Prevention of cervical cancer
SS 2017: Prevention of cervical cancer
 
SS 2017: Novel Strategies to Improve STI Screening
SS 2017: Novel Strategies to Improve STI ScreeningSS 2017: Novel Strategies to Improve STI Screening
SS 2017: Novel Strategies to Improve STI Screening
 
SS 2017: The resistance march
SS 2017: The resistance marchSS 2017: The resistance march
SS 2017: The resistance march
 
SS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
SS 2017: Pre-exposure prophylaxis Sexually Transmitted InfectionsSS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
SS 2017: Pre-exposure prophylaxis Sexually Transmitted Infections
 
SS 2017: Syphilis in post elimination era - control strategies
SS 2017: Syphilis in post elimination era - control strategiesSS 2017: Syphilis in post elimination era - control strategies
SS 2017: Syphilis in post elimination era - control strategies
 
SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”
 
SS 2017: Diagnosis of Vaginal Conditions
SS 2017: Diagnosis of Vaginal ConditionsSS 2017: Diagnosis of Vaginal Conditions
SS 2017: Diagnosis of Vaginal Conditions
 
SS 2017: National Programme for Tuberculosis Control and Chest Diseases-NPTCCD
SS 2017: National Programme for Tuberculosis Control and Chest Diseases-NPTCCDSS 2017: National Programme for Tuberculosis Control and Chest Diseases-NPTCCD
SS 2017: National Programme for Tuberculosis Control and Chest Diseases-NPTCCD
 
Detection of HIV-TB co infection New approaches
Detection of HIV-TB co infectionNew approachesDetection of HIV-TB co infectionNew approaches
Detection of HIV-TB co infection New approaches
 
CPD 2017: HIV Histopathology
CPD 2017: HIV HistopathologyCPD 2017: HIV Histopathology
CPD 2017: HIV Histopathology
 
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
2016 Sessions: Perinatal, Paediatric and adolescence: What are the HIV Priori...
 
2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management
 
2016 Sesions: Liver and HIV
2016 Sesions: Liver and HIV2016 Sesions: Liver and HIV
2016 Sesions: Liver and HIV
 
2016 Sessions: Mother to child transmission of HIV
2016 Sessions: Mother to child transmission of HIV2016 Sessions: Mother to child transmission of HIV
2016 Sessions: Mother to child transmission of HIV
 

Recently uploaded

nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetnagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Call Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in Anantapur
Call Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in AnantapurCall Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in Anantapur
Call Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in Anantapur
gragmanisha42
 
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetHubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
9316020077📞Goa  Call Girls  Numbers, Call Girls  Whatsapp Numbers Goa9316020077📞Goa  Call Girls  Numbers, Call Girls  Whatsapp Numbers Goa
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
russian goa call girl and escorts service
 
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMuzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
palanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
palanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetpalanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
palanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
mriyagarg453
 
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetneemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
coimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
coimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetcoimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
coimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetTirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 

Recently uploaded (20)

Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girlKolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
 
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetnagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur RajasthanJaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
 
Call Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in Anantapur
Call Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in AnantapurCall Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in Anantapur
Call Girls Service Anantapur 📲 6297143586 Book Now VIP Call Girls in Anantapur
 
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetHubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
9316020077📞Goa  Call Girls  Numbers, Call Girls  Whatsapp Numbers Goa9316020077📞Goa  Call Girls  Numbers, Call Girls  Whatsapp Numbers Goa
9316020077📞Goa Call Girls Numbers, Call Girls Whatsapp Numbers Goa
 
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMuzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
palanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
palanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetpalanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
palanpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
 
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bareilly Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
 
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetneemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
coimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
coimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetcoimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
coimbatore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetTirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Kochi call girls Mallu escort girls available 7877702510
Kochi call girls Mallu escort girls available 7877702510Kochi call girls Mallu escort girls available 7877702510
Kochi call girls Mallu escort girls available 7877702510
 
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 

Scientific Sessions 2015: STI in MSM

  • 1. STIs in men who have sex with men (MSM) Dr Katie Conway October 2015
  • 2. Introduction • Epidemiology of STIs in MSM • Reasons for high rates in MSM • Changing epidemics • Cases • Learning points
  • 4. PHE report on MSM in London - 2014 • 2% of London adult population • 24% of all new STI diagnoses • Rising rates of STIs – 46% syphilis – 32% gonorrhoea – 26% chlamydia • High re-infection rates • High burden of gonorrhoea and syphilis Public Health England: HIV and STIs in men who have sex with men in London, September 2014
  • 5. Public Health England: HIV and STIs in men who have sex with men in London, September 2014
  • 6. Percentage of all STI diagnoses in men which were among MSM: England, 2009-2013 39 Public Health England: 2013 STI Slide Set • Data from routine GUM service returns • * First episode; **Includes diagnoses of primary, secondary & early latent syphilis • Chlamydia data from 2012 onwards are not comparable to data from previous years (please see ‘Notes’ slide for more details) • Data type: service data
  • 7.
  • 8. HIV • 50% new diagnoses are in MSM • Globally MSM have disproportionate burden of HIV infection
  • 10.
  • 11. HIV in SriLanka National STD/AIDS Control Programme Annual Report 2014
  • 13. STI / HIV transmission in MSM Biological Behavioural Social
  • 14. HIV transmission in MSM • Biological factors – Receptive anal sex – Concurrent STIs – often asymptomatic
  • 15. Behavioural • High partner numbers: – EMIS1 2010: 60% sexual contact within 7 days 70% >1 partner within 12 months HIV –ve MSM 34% 10 partners in 1 year – NATSAL 20002: Skewed distribution Median 1 partner per year 15% > 10 partners per year – Overlapping / concurrent partners – Sexual mixing of MSM with high and low partner no.s 1EMIS. Vital Statistics 2010:The UK Gay Men's Sex Survey Data Report All London SHA by PCT area of residence. 2010. 2Mercer C Fk et al. Increasing prevalence of male homosexual partnershipsand practices in Britain 1990-2000: evidence from national probability surveys. AIDS 2004. 2004;18:1453-8.
  • 16. Behavioural • Survey MSM London gyms3: 36% UPAI in last 3/12 • EMIS1: 40% UPAI last sexual intercourse • GMSHS, 20084; in the last year: – UPAI in HIV +ve MSM – 57.7% (49.6% in 2000) – UPAI in HIV –ve MSM – 46.6% (42.2% in 2000) • Seroadaptive behaviour • ‘Chemsex’ 3Lattimore S TA et al; Changing patterns of sexual risk behavior among London gay men: 1998-2008. Sex Transm Dis. 2011;38(3):221-9. 4Wayal S FS et al; Gay Men's Sexual Health Survey, London 2008. Centre for Sexual Health & HIV Research, Research Department of Infection & Population health, University College London, 2008.
  • 17. Other factors • Stigma • Rates of engagement with services (UK) • Often ‘hidden’ epidemics in many countries • Often difficult partner notification • High rates of depression / mental health problems
  • 18.
  • 19. Depression and sexual behaviour in MSM – Aurah study. BASHH 2015
  • 20. STIs in MSM Specific epidemics: • Lymphogranuloma Venereum (LGV) • Shigella flexneri • Hepatitis C (HCV) • Syphilis
  • 21. LGV • Chlamydia trachomatis • D to K = genital infection • L1 , L2 & L3 = lymphogranuloma venereum (LGV) – Infect lymphocytes & macrophages – Invasive pathogens • Primary – ulcer / proctitis (98%) – Incubation period 4-21 days • Secondary – inguinal syndrome – Incubation period 10 days to 6 months • Tertiary stages
  • 22. 1980s Original descriptions of MSM with LGV proctitis in Seattle & San Francisco 1990s LGV not reported in Western MSM Jan 2003 First of four cases of LGV in Hamburg MSM, 2003 Australian LGV L2 bubo case - no travel history Aug 2004 Dutch LGV cases reach >100 Sep 2004 Oct 2004 First US cases in San Francisco Nov 2004 Dec 2004 Barcelona case First Swedish & Canadian cases Jan 2004 Appearance of LGV in Rotterdam, then Amsterdam, Antwerp and Paris Feb 2003 Sustained LGV outbreaks within Europe, UK and USA 2005-2014 2000 to 2003 Retrospective analysis of MSM rectal specimens Amsterdam, Paris and London = 126 cases LGV L2 A recent timeline of LGV infection in MSM
  • 23. LGV Public Health England: HIV and STIs in men who have sex with men in London, September 2014
  • 24. LGV • Associations: – 82% HIV +ve; 20% Hep C Ab +ve – UPAI – Fisting – Partners through the internet / saunas / sex parties – Dense sexual networks – Simultaneous contacts – Poly-drug use Health Protection Agency. Syphilis and Lymphogranuloma Venereum: Resurgent Sexually Transmitted Infections in the UK. In: Agency HP, editor. 2009.
  • 25. Shigella flexneri 3a isolates, adult males with no/unknown travel history: 2005-2013 • 750% rise 2008-13 • 60% cases in London
  • 26. Hepatitis C • 2002-2006: 20% increase in incidence per year • HIV positive MSM • Associated with: – Previous syphilis infection – Another recent STI diagnosis – UPAI – IDU – Recreational drug use – High rates of partner change Public Health England: HIV and STIs in men who have sex with men in London, September 2014
  • 27. Syphilis • Treponema Pallidum – spirochete bacterium • Transmission – sexual / vertical /(blood borne) • 1/3 sexual contacts of infectious syphilis will develop disease • 4 stages: – Primary / secondary / early latent - infectious – Late latent – Tertiary • Histopathological hallmarks: – Endarteritis – Plasma cell–rich infiltrate
  • 28.
  • 29. Cases
  • 30. Case 1 • 25 year old MSM, Italian • No PMH / DH • PC: – Worsening perianal pain and discharge 2/12 – Accident and Emergency department 04/2015 – Admitted under surgical team – Diagnosed with a fissure – Discharged with diltiazem topical cream
  • 31. Case 1 • Seen in surgical OP 6 weeks later • Ongoing symptoms • Took a sexual history and referred to GU clinic • Examination: – Perianal ulcer – Rectal discharge and contact bleeding • Full STI screen done • Treated empirically with doxycycline and aciclovir
  • 32. Case 1 • Provisional results: – Treponema pallidum antibody positive – RPR 1:64 – Ulcer swab – TP PCR positive (HSV negative) – HIV 1 Ag/Ab positive – Rectal CT NAAT positive – Rectal GC NAAT positive – Hepatitis C antibodies positive
  • 33. Case 1 • Treated with: – Ceftriaxone 500mg im – Doxycycline completed 3 weeks • LGV specific DNA positive • HIV – CD4 1446 cells/mm3 – VL 76000 copies/mL • Hepatitis C RNA 4 million • Genotype 1a
  • 34. Issues • Partner notification: – Reported 1 RMP since last sexual health screen 3 months before • Further management – Offer HIV treatment • Hepatitis C treatment - discuss • Feedback to surgical team and A&E
  • 35. Case 2 • 60 year old MSM • HIV positive, stable on ART • CD4 600, VL < 20 copies/mL • RMP – monogamous relationship, 2 years • Presented to GP with right inguinal lump • Referred to surgeons ? Hernia • US – lymph node mass
  • 36. Case 2 • Discussed the differential diagnoses: – Syphilis – LGV – Lymphoma – Mycobacterial infection – KS
  • 37. Case 2 • Partner admits he was diagnosed with syphilis few days ago… • Treated with benzathine penicillin and doxycycline 3/52 to cover both syphilis and LGV
  • 38. Case 2 • Results: • TP Antibody positive • RPR 1:128 • Rectal, throat and urine NAATs negative for GC/CT • After 1 week – LN still enlarged and painful
  • 39. Case 2 • Repeat US – no collection • FNA: – no malignant cells – AFB smear negative – NAAT positive for chlamydia – LGV specific DNA detected • Completed 3 weeks of doxycycline • Buboe ruptured • Required a further 1 week Azithromycin until resolved
  • 40. Case 3 • 46 year old MSM • Unwell for >6 months • Chronic diarrhoea • Peeling skin • “covered in rashes” • Patchy alopecia • Seen in private sector ? Psoriasis ? IBD
  • 41. Hands
  • 43. Feet
  • 44. • Seen by several specialties • Several investigations done including colonoscopies • Treated with prednisolone and mesalazine for ?eosinophilic colitis and for psoriasis • Everything got worse • HIV serology: positive • Last negative test was 18/12 before
  • 45. • Referred to GU services • Diagnosed with secondary syphilis • Confirmatory serology: – treponemal antibody detected – RPR 1:512 • Rectal chlamydia & gonorrhoea positive • Pharyngeal gonorrhoea positive • Treated with doxycycline (penicillin allergy)
  • 47.
  • 48. RPR follow up • Skin & hair much better • Started ARVs • Doing well • Feedback to other specialties – gastro / derm
  • 49. Case 4 • 35 year old eastern European man • Found acting oddly on public transport • Confused ?had a seizure • Dropped GCS on admission • Febrile & tachycardic • HIV test positive
  • 50. Imaging • Initial CT Brain: low attenuation L internal capsule ?acute infarct • Repeat 3/7 later: large R MCA infarct with midline shift • CD4 count 154 cells/mm3, VL 93703 copies/mL • Wide differential: opportunistic infections vs non HIV
  • 51. Other investigations • CSF: WCC 27, protein 1.04, normal glucose ratio • CSF virology: negative • Treponemal DNA DETECTED • Serology: – Treponemal antibody DETECTED – RPR 1:256
  • 53. Conclusion: • Large subacute right MCA territory infarct with additional smaller infarcts in the left MCA and right ACA territory. • MRA shows distal ICA and MCA occlusion on the right side and moderate to severe terminal ICA and A1/M1 origin narrowing on the left side Suggestive of a vasculitic process Presumed diagnosis: meningovascular syphilis
  • 54. Treatment • Started on intravenous benzylpenicillin every 4hrs • Also given steroids • Unfortunately deterioration of condition despite full active treatment • Deemed in best interests to be DNAR • Died within 4 weeks of admission
  • 55. Learning points • STIs and HIV common in MSM • Often concurrent infections • Often present to other services • Communication and education very important • STI epidemiology can change • Surveillance is key • In HIV, STIs are often atypical
  • 56.
  • 57. Thank you for your attention!

Editor's Notes

  1. Notes: Percentage of all STI diagnoses in men which were among MSM: England, 2009-2013 The increased number of STIs reported in MSM accounts for the majority of increased diagnoses seen among all males in recent years. In 2013, over 80% of all syphilis diagnoses in men were among MSM. Over 60% of gonorrhoea diagnoses in men were among MSM.
  2. 22
  3. So, why are we concerned about Shigella and why was an Outbreak Control team convened? As you can see, between 2008 and 2013 there was a rapid increase in cases of non travel associated Shigella in adult males. This represented a 750% increase over this time, with 60% of the cases coming from London, also larger numbers coming from Greater Manchester (blue) and Brighton(light grey). Sexual orientation is not collected for Shigella, but being concentrated in MSM areas, we assumed it was MSM focused.